首页 | 本学科首页   官方微博 | 高级检索  
     

微RNA-125a靶向白细胞介素23受体信号通路抑制HaCaT细胞增殖机制的初步研究
引用本文:苏芳 晋亮 李浩 丁英洁 孙晓杰 孙晓冬 刘玮 徐桂娟 王强 刘永斌. 微RNA-125a靶向白细胞介素23受体信号通路抑制HaCaT细胞增殖机制的初步研究[J]. 中华皮肤科杂志, 2021, 54(6): 499-503. DOI: 10.35541/cjd.20200707
作者姓名:苏芳 晋亮 李浩 丁英洁 孙晓杰 孙晓冬 刘玮 徐桂娟 王强 刘永斌
作者单位:1沈阳市第七人民医院皮肤科110003;2空军特色医学中心皮肤科,北京100142
基金项目:辽宁省科学技术计划项目(2019?ZD?0975);沈阳市中青年科技创新人才支持计划项目(RC200417)
摘    要:目的 探讨微RNA(miR)-125a抑制角质形成细胞增殖的相关机制.方法 用白细胞介素(IL)-23干预处理人永生化角质形成细胞(HaCaT)24h后,分为miR-125a组和miR-NC组,分别转染miR-125a过表达质粒和过表达对照质粒.采用细胞计数试剂盒(CCK8)法检测两组转染后0、24、48、72 h H...

关 键 词:银屑病  角蛋白细胞  微RNAs  细胞增殖  白细胞介素23  微RNA-125a
收稿时间:2020-07-13

Mechanisms underlying microRNA-125a-mediated inhibition of proliferation of HaCaT cells by targeting the interleukin 23 receptor signaling pathway: a preliminary study
Su Fang,Jin Liang,Li Hao,Ding Yingjie,Sun Xiaojie,Sun Xiaodong,Liu Wei,Xu Guijuan,Wang Qiang,Liu Yongbin. Mechanisms underlying microRNA-125a-mediated inhibition of proliferation of HaCaT cells by targeting the interleukin 23 receptor signaling pathway: a preliminary study[J]. Chinese Journal of Dermatology, 2021, 54(6): 499-503. DOI: 10.35541/cjd.20200707
Authors:Su Fang  Jin Liang  Li Hao  Ding Yingjie  Sun Xiaojie  Sun Xiaodong  Liu Wei  Xu Guijuan  Wang Qiang  Liu Yongbin
Affiliation:1Department of Dermatology, The Seventh People′s Hospital of Shenyang, Shenyang 110003, China; 2Department of Dermatology, Air Force Medical Center, Beijing 100142, China
Abstract:【Abstract】 Objective To explore the mechanism underlying microRNA (miR)-125a-mediated inhibition of proliferation of keratinocytes. Methods After 24-hour pretreatment with interleukin (IL)-23, human HaCaT keratinocytes were divided into miR-125a group and miR-NC group transfected with a miR-125a overexpression plasmid and a control plasmid, respectively. Cell counting kit-8 (CCK8) assay was performed to evaluate the proliferative ability of HaCaT cells in the two groups at 0, 24, 48 and 72 hours after transfection, real-time fluorescence-based quantitative PCR to determine the mRNA expression of miR-125a and IL-23 receptors (IL-23R) in the two groups 24 hours after transfection, and Western blot analysis to determine the protein expression of IL-23R, Janus kinase 2 (JAK2), protein kinase B (AKT) and phosphorylated AKT (p-AKT) in the two groups 48 hours after transfection. Dual-luciferase reporter assay was performed to verify the targeting relationship between miR-125a and IL-23R. Comparison of means between two groups was carried out by using t test, and changes in the proliferative ability of HaCaT cells over time were evaluated by using repeated measures analysis of variance. Results After plasmid transfection, the relative expression of miR-125a was significantly higher in the miR-125a group (6.377 ± 0.745) than in the miR-NC group (0.700 ± 0.222; t = 7.305, P = 0.002). At 0, 24 and 48 hours after transfection, there was no significant difference in cellular proliferative ability between the miR-125a group and the miR-NC group (t = 0.663, 0.623 and 1.930, respectively, all P > 0.05); at 72 hours after transfection, the cellular proliferative ability was significantly lower in the miR-125a group than in the miR-NC group (t = 4.407, P < 0.05). The IL-23R mRNA expression was significantly lower in the miR-125a group than in the miR-NC group (t = 3.082, P < 0.05). Compared with the miR-NC group, the miR-125a group showed significantly decreased protein expression of IL-23R, JAK2 and p-AKT (t = 11.715, 6.996, 12.424, P < 0.001, = 0.002, < 0.001, respectively). Dual-luciferase reporter assay showed targeted binding of miR-125a to IL-23R. Conclusion MiR-125a may inhibit the proliferation of keratinocytes by negatively regulating the IL-23R/JAK2/AKT signaling pathway.
Keywords:Psoriasis   Keratinocytes   MicroRNAs   Cell proliferation   Interleukin-23   MicroRNA-125a  
点击此处可从《中华皮肤科杂志》浏览原始摘要信息
点击此处可从《中华皮肤科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号